Morphological and molecular alterations in 1,2 dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Perše, Martina ^a   Cerar, Anton ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; APC PROTEIN; AZOXYMETHANE; BETA CATENIN; BIOLOGICAL MARKER; CYCLOOXYGENASE 2; K RAS PROTEIN; MUCIN; MYC PROTEIN; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; WNT PROTEIN; TUMOR MARKER;

ABERRANT CRYPT FOCUS; ASCENDING COLON; CANCER GENETICS; CANCER MODEL; CANCER STAGING; CHROMOSOMAL INSTABILITY; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL ADENOMA; DESCENDING COLON; ENVIRONMENTAL FACTOR; EPITHELIUM DYSPLASIA; EPITHELIUM HYPERPLASIA; EPITHELIUM TUMOR; EXPERIMENTAL RAT; GASTROINTESTINAL DYSPLASIA; GENE FREQUENCY; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; MICROSATELLITE INSTABILITY; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECTUM CARCINOMA; REVIEW; SIGNAL TRANSDUCTION; TREATMENT PLANNING; ANIMAL; CHEMICALLY INDUCED DISORDER; COLON TUMOR; GENETICS; METABOLISM; NOMENCLATURE; PATHOLOGY; PRECANCER; RAT;

RATTUS;

1,2-DIMETHYLHYDRAZINE; ANIMALS; AZOXYMETHANE; COLONIC NEOPLASMS; HUMANS; PRECANCEROUS CONDITIONS; RATS; TERMINOLOGY AS TOPIC; TUMOR MARKERS, BIOLOGICAL;

EID: 79952219337     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/473964     Document Type: Review

References (113)

1. Parkin D. M., Bray F., Ferlay J., Pisani P., Global cancer statistics, 2002 CA Cancer (Pubitemid 40372904)
2. Kim Y. S., Milner J. A., Dietary modulation of colon cancer risk Journal of Nutrition 2007 137 11 S2576 S2579
3. Tammariello A. E., Milner J. A., Mouse models for unraveling the importance of diet in colon cancer prevention Journal of Nutritional Biochemistry 2010 21 2 77 88
4. Corpet D. E., Pierre F., How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men European Journal of Cancer 2005 41 13 1911 1922 (Pubitemid 41557677)
5. Wargovich M. J., Jimenez A., McKee K., Steele V. E., Velasco M., Woods J., Price R., Gray K., Kelloff G. J., Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression Carcinogenesis 2000 21 6 1149 1155 (Pubitemid 30389340)
6. Heyer J., Yang K., Lipkin M., Edelmann W., Kucherlapati R., Mouse models for colorectal cancer Oncogene 1999 18 38 5325 5333 (Pubitemid 29462368)
7. Femia A. M., Caderni G., Rodent models of colon carcinogenesis for the study of chemopreventive activity of natural products Planta Medica 2008 74 13 1602 1607
8. Pere M., Cerar A., The dimethylhydrazine induced colorectal tumours in ratexperimental colorectal carcinogenesis Radiology and Oncology 2005 39 1 61 87
9. Bird R. P., Hanausek M., Walaszek Z., Aberrant crypt foci system to study cancer preventive agents in the colon Methods in Molecular Medicine: Tumor Marker Protocols 1998 Totowa, NJ, USA Humana Press 465 474
10. Nakagama H., Ochiai M., Ubagai T., Tajima R., Fujiwara K., Sugimura T., Nagao M., A rat colon cancer model induced by 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine, PhIP Mutation Research 2002 506-507 137 144 (Pubitemid 35286548)
11. Banerjee A., Quirke P., Experimental models of colorectal cancer Diseases of the Colon and Rectum 1998 41 4 490 505 (Pubitemid 28169676)
12. Rosenberg D. W., Giardina C., Tanaka T., Mouse models for the study of colon carcinogenesis Carcinogenesis 2009 30 2 183 196
13. Chen J., Huang XU. F., The signal pathways in azoxymethane-induced colon cancer and preventive implications Cancer Biology amp; Therapy 2009 8 14 1313 1317
14. Takahashi M., Wakabayashi K., Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents Cancer Science 2004 95 6 475 480 (Pubitemid 38832695)
15. Fiala E. S., Stathopoulos C., Metabolism of methylazoxymethanol acetate in the F344 rat and strain-2 guinea pig and its inhibition by pyrazole and disulfiram Journal of Cancer Research and Clinical Oncology 1984 108 1 129 134 (Pubitemid 14095235)
16. Glauert H. P., Bennink M. R., Metabolism of 1,2-dimethylhydrazine by cultured rat colon epithelial cells Nutrition and Cancer 1983 5 2 78 86 (Pubitemid 14205632)
17. Oravec C. T., Jones C. A., Huberman E., Activation of the colon carcinogen 1,2-dimethylhydrazine in a rat colon cell-mediated mutagenesis assay Cancer Research 1986 46 10 5068 5071 (Pubitemid 16008268)
18. Chang W. W. L., Histogenesis of colon cancer in experimental animals Scandinavian Journal of Gastroenterology 1984 19 supplement 27 43 (Pubitemid 15191683)
19. Shirai T., Nakanowatari J., Kurata Y., Different dose-response relationships in the induction of different types of colonic tumors in wistar rats by 1,2-dimethylhydrazine Gann, The Japanese Journal of Cancer Research 1983 74 1 21 27 (Pubitemid 13119026)
20. Veeri Z., Cerar A., Comparison of Wistar vs. Fischer rat in the incidence of 1,2-dimethylhydrazine induced intestinal tumors Radiology and Oncology 2004 38 3 227 247
21. Breskvar L., Cerar A., A role of gender in the occurrence of dimethylhydrazine induced colorectal tumors in Wistar rats Radiology and Oncology 1997 31 4 374 379 (Pubitemid 28131168)
22. McMahon T. F., Peggins J. O., Centra M. M., Weiner M., Age-related changes in biotransformation of azoxymethane and methylazoxymethanol in vitro Xenobiotica 1990 20 5 501 513 (Pubitemid 20141950)
23. Magnuson B. A., South E. H., Exon J. H., Dashwood R. H., Xu M., Hendrix K., Hubele S., Increased susceptibility of adult rats to azoxymethane-induced aberrant crypt foci Cancer Letters 2000 161 2 185 193
24. Bird R. P., Good C. K., The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer Toxicology Letters 2000 112-113 395 402 (Pubitemid 30138150)
25. Bird R. P., Role of aberrant crypt foci in understanding the pathogenesis of colon cancer Cancer Letters 1995 93 1 55 71
26. Tanaka T., Colorectal carcinogenesis: review of human and experimental animal studies Journal of Carcinogenesis 2009 8, article 5
27. Mori H., Yamada Y., Kuno T., Hirose Y., Aberrant crypt foci and -catenin accumulated crypts; significance and roles for colorectal carcinogenesis Mutation Research 2004 566 3 191 208 (Pubitemid 38472027)
28. Mori H., Hata K., Yamada Y., Kuno T., Hara A., Significance and role of early-lesions in experimental colorectal carcinogenesis Chemico-Biological Interactions 2005 155 1-2 1 9 (Pubitemid 40835985)
29. Boivin G. P., Washington K., Yang K., Ward J. M., Pretlow T. P., Russell R., Besselsen D. G., Godfrey V. L., Doetschman T., Dove W. F., Pitot H. C., Halberg R. B., Itzkowltz S. H., Groden J., Coffey R. J., Pathology of mouse models of intestinal cancer: consensus report and recommendations Gastroenterology 2003 124 3 762 777 (Pubitemid 36268493)
30. Caderni G., Femia A. P., Giannini A., Favuzza A., Luceri C., Salvadori M., Dolara P., Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis Cancer Research 2003 63 10 2388 2392 (Pubitemid 36605173)
31. Bird R. P., Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings Cancer Letters 1987 37 2 147 151 (Pubitemid 17157833)
32. Lu Q., Jiang BO., Lin C., Shan T., Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat Journal of Experimental and Clinical Cancer Research 2008 27 1, article 26
33. Paulsen J. E., Lberg E. M., lstrn H. B., Knutsen H., Steffensen I. L., Alexander J., Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat Cancer Research 2005 65 1 121 129 (Pubitemid 40073652)
34. Ochiai M., Watanabe M., Nakanishi M., Taguchi A., Sugimura T., Nakagama H., Differential staining of dysplastic aberrant crypt foci in the colon facilitates prediction of carcinogenic potentials of chemicals in rats Cancer Letters 2005 220 1 67 74 (Pubitemid 40312019)
35. Yamada Y., Yoshimi N., Hirose Y., Kawabata K., Matsunaga K., Shimizu M., Hara A., Mori H., Frequent -catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis Cancer Research 2000 60 13 3323 3327 (Pubitemid 30482139)
36. Pretlow T. P., Barrow B. J., Ashton W. S., O'Riordan M. A., Pretlow T. G., Jurcisek J. A., Stellato T. A., Aberrant crypts: putative preneoplastic foci in human colonic mucosa Cancer Research 1991 51 5 1564 1567
37. Pretlow T. P., Pretlow T. G., Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochimica et Biophysica Acta 2005 1756 2 83 96 (Pubitemid 41781960)
38. Cheng L., Lai M. D., Aberrant crypt foci as microscopic precursors of colorectal cancer World Journal of Gastroenterology 2003 9 12 2642 2649 (Pubitemid 38054431)
39. Pretlow T. P., O'Riordan M. A., Spancake K. M., Pretlow T. G., Two types of putative preneoplastic lesions identified by hexosaminidase activity in whole-mounts of colons from F344 rats treated with carcinogen American Journal of Pathology 1993 142 6 1695 1700 (Pubitemid 24057063)
40. Otori K., Sugiyama K., Hasebe T., Fukushima S., Esumi H., Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation Cancer Research 1995 55 21 4743 4746
41. McLellan E. A., Medline A., Bird R. P., Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions Cancer Research 1991 51 19 5270 5274
42. Raju J., Azoxymethane-induced rat aberrant crypt foci: relevance in studying chemoprevention of colon cancer World Journal of Gastroenterology 2008 14 43 6632 6635
43. Park H. S., Goodlad R. A., Wright N. A., The incidence of aberrant crypt foci and colonic carcinoma in dimethylhydrazine-treated rats varies in a site-specific manner and depends on tumor histology Cancer Research 1997 57 20 4507 4510 (Pubitemid 27441053)
44. Rodrigues M. A. M., Silva L. A. G., Salvadori D. M. F., De Camargo J. L. V., Montenegro M. R., Aberrant crypt foci and colon cancer: comparison between a short-and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats Brazilian Journal of Medical and Biological Research 2002 35 3 351 355 (Pubitemid 34285508)
45. Ghirardi M., Nascimbeni R., Villanacci V., Fontana M. G., Di Betta E., Salerni B., Azoxymethane-induced aberrant crypt foci and colorectal tumors in F344 rats: sequential analysis of growth European Surgical Research 1999 31 3 272 280 (Pubitemid 29261371)
46. Femia A. P., Bendinelli B., Giannini A., Salvadori M., Pinzani P., Dolara P., Caderni G., Mucin-depleted foci have -catenin gene mutations, altered expression of its protein, and are dose-and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats International Journal of Cancer 2005 116 1 9 15 (Pubitemid 40827749)
47. Femia A. P., Tarquini E., Salvadori M., Ferri S., Giannini A., Dolara P., Caderni G., K-ras mutations and mucin profile in preneoplastic lesions and colon tumors induced in rats by 1,2-dimethylhydrazine International Journal of Cancer 2008 122 1 117 123 (Pubitemid 350209985)
48. Femia A. P., Dolara P., Giannini A., Salvadori M., Biggeri A., Caderni G., Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis Cancer Research 2007 67 2 445 449 (Pubitemid 46192179)
49. Femia A. P., Dolara P., Luceri C., Salvadori M., Caderni G., Mucin-depleted foci show strong activation of inflammatory markers in 1,2-dimethylhydrazine-induced carcinogenesis and are promoted by the inflammatory agent sodium dextran sulfate International Journal of Cancer 2009 125 3 541 547
50. Pietro Femia A., Dolara P., Caderni G., Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomakers for colon carcinogenesis Carcinogenesis 2004 25 2 277 281 (Pubitemid 38239810)
51. Yamada Y., Yoshimi N., Hirose Y., Matsunaga K., Katayama M., Sakata K., Shimizu M., Kuno T., Mori H., Sequential analysis of morphological and biological properties of -catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis Cancer Research 2001 61 5 1874 1878 (Pubitemid 32692002)
52. Yoshimi N., Morioka T., Kinjo T., Inamine M., Kaneshiro T., Shimizu T., Suzui M., Yamada Y., Mori H., Histological and immunohistochemical observations of mucin-depleted foci (MDF) stained with Alcian blue, in rat colon carcinogenesis induced with 1,2-dimethylhydrazine dihydrochloride Cancer Science 2004 95 10 792 797 (Pubitemid 39545584)
53. Femia A. P., Paulsen J. E., Dolara P., Alexander J., Caderni G., Correspondence between flat aberrant crypt foci and mucin-depleted foci in rodent colon carcinogenesis Anticancer Research 2008 28 6 A 3771 3775
54. Sparks A. B., Morin P. J., Vogelstein B., Kinzler K. W., Mutational analysis of the APC/ -catenin/Tcf pathway in colorectal cancer Cancer Research 1998 58 6 1130 1134 (Pubitemid 28183198)
55. Bird R. P., Salo D., Lasko C., Good C., A novel methodological approach to study the level of specific protein and gene expression in aberrant crypt foci putative preneoplastic colonic lesions by Western blotting and RT-PCR Cancer Letters 1997 116 1 15 19 (Pubitemid 27226144)
56. Liu C., Crawford J., Kumar V., Abbas A., Fausto N., The gastrointestinal tract Robbins and Cotran Patologic Basis of Disease 2004 Elsevier Saunders 797 875
57. Morin P. J., Sparks A. B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K. W., Activation of -catenin-Tcf signaling in colon cancer by mutations in -catenin or APC Science 1997 275 5307 1787 1790 (Pubitemid 27136715)
58. De Filippo C., Caderni G., Bazzicalupo M., Briani C., Giannini A., Fazi M., Dolara P., Mutations of the Apc gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats British Journal of Cancer 1998 77 12 2148 2151 (Pubitemid 28263934)
59. Sohn K. J., Puchyr M., Salomon R. N., Graeme-Cook F., Fung L., Choi S. W., Mason J. B., Medline A., Kim Y. I., The effect of dietary folate on Apc and p53 mutations in the dimethylhydrazine rat model of colorectal cancer Carcinogenesis 1999 20 12 2345 2350 (Pubitemid 30015910)
60. Blum C. A., Tanaka T., Zhong X., Li Q., Dashwood W. M., Pereira C., Xu M., Dashwood R. H., Mutational analysis of Ctnnb1 and Apc in tumors from rats given 1,2-dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f]quinoline: mutational 'hotspots' and the relative expression of -catenin and c-jun Molecular Carcinogenesis 2003 36 4 195 203 (Pubitemid 36418738)
61. Femia A. P., Luceri C., Toti S., Giannini A., Dolara P., Caderni G., Gene expression profile and genomic alterations in colonic tumours induced by 1,2-dimethylhydrazine (DMH) in rats BMC Cancer 2010 10, article 194
62. Takahashi M., Mutoh M., Kawamori T., Sugimura T., Wakabayashi K., Altered expression of -catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis Carcinogenesis 2000 21 7 1319 1327 (Pubitemid 30455990)
63. Takahashi M., Fukuda K., Sugimura T., Wakabayashi K., -catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors Cancer Research 1998 58 1 42 46 (Pubitemid 28027714)
64. Hajdch M., Jank S., Drbek J., Radzioch D., Clinical relevance of KRAS in human cancers Journal of Biomedicine and Biotechnology 2010 2010
65. Vivona A. A., Shpitz B., Medline A., Bruce W. R., Hay K., Ward M. A., Stern H. S., Gallinger S., K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis Carcinogenesis 1993 14 9 1777 1781 (Pubitemid 23290888)
66. Erdman S. H., Wu H. D., Hixson L. J., Ahnen D. J., Gerner E. W., Assessment of mutations in Ki-ras and p53 in colon cancers from azoxymethane- and dimethylhydrazine-treated rats Molecular Carcinogenesis 1997 19 2 137 144 (Pubitemid 27296744)
67. Luceri C., De Filippo C., Caderni G., Gambacciani L., Salvadori M., Giannini A., Dolara P., Detection of somatic DNA alterations in azoxymethane-induced F344 rat colon tumors by random amplified polymorphic DNA analysis Carcinogenesis 2000 21 9 1753 1756
68. Bissonnette M., Khare S., Von Lintig F. C., Wali R. K., Nguyen L., Zhang Y., Hart J., Skarosi S., Varki N., Boss G. R., Brasitus T. A., Mutational and nonmutational activation of p21 in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1 Cancer Research 2000 60 16 4602 4609 (Pubitemid 32103646)
69. Jacoby R. F., Llor X., Teng B. B., Davidson N. O., Brasitus T. A., Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa Journal of Clinical Investigation 1991 87 2 624 630
70. Stopera S. A., Murphy L. C., Bird R. P., Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer Carcinogenesis 1992 13 11 2081 2085
71. Perse M., Mlinaric V., Cerar A., Aberrant crypt foci as biomarkers predictive of colorectal carcinoma Slovenian Medical Journal 2010 79 6 499 506
72. Shivapurkar N., Nikula K. J., Tanaka T., Tang Z. C., Alabaster O., Absence of p53 gene mutations in rat colon carcinomas induced through the synergistic interaction between methylazoxymethanol and X-irradiation Cancer Letters 1997 113 1-2 9 16 (Pubitemid 27113222)
73. Shivapurkar N., Belinsky S. A., Wolf D. C., Tang Z., Alabaster O., Absence of p53 gene mutations in rat colon carcinomas induced by azoxymethane Cancer Letters 1995 96 1 63 70
74. Stopera S. A., Bird R. P., Immunohistochemical demonstration of mutant p53 tumour suppressor gene product in aberrant crypt foci Cytobios 1993 73 293 73 88
75. Orlando F. A., Tan D., Baltodano J. D., Khoury T., Gibbs J. F., Hassid V. J., Ahmed B. H., Alrawi S. J., Aberrant crypt foci as precursors in colorectal cancer progression Journal of Surgical Oncology 2008 98 3 207 213
76. Ravnik-Glavac M., Cerar A., Glavac D., Animal model in the study of colorectal carcinogenesis Pflugers Archiv European Journal of Physiology 2000 440 5 R55 R57
77. Takahashi M., Nakatsugi S., Sugimura T., Wakabayashi K., Frequent mutations of the -catenin gene in mouse colon tumors induced by azoxymethane Carcinogenesis 2000 21 6 1117 1120 (Pubitemid 30389335)
78. De Jong T. A., Skinner S. A., Malcontenti-Wilson C., Vogiagis D., Bailey M., Van Driel I. R., O'Brien P. E., Inhibition of rat colon tumors by sulindac and sulindac sulfone is independent of K-ras (codon 12) mutation American Journal of Physiology-Gastrointestinal and Liver Physiology 2000 278 2 G266 G272
79. Kishimoto Y., Morisawa T., Hosoda A., Shiota G., Kawasaki H., Hasegawa J., Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane Journal of Experimental and Clinical Cancer Research 2002 21 2 203 211 (Pubitemid 34785556)
80. Bordonaro M., Modular Cre/lox system and genetic therapeutics for colorectal cancer Journal of Biomedicine and Biotechnology 2009 2009
81. Jin T., George Fantus I., Sun J., Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of -catenin Cellular Signalling 2008 20 10 1697 1704
82. Kolligs F. T., Bommer G., Gke B., Wnt/beta-catenin/Tcf signaling: a critical pathway in gastrointestinal tumorigenesis Digestion 2002 66 3 131 144 (Pubitemid 36091845)
83. Xing Pei Hao., Pretlow T. G., Rao J. S., Pretlow T. P., -catenin expression is altered in human colonic aberrant crypt foci Cancer Research 2001 61 22 8085 8088 (Pubitemid 33091594)
84. Wali R. K., Khare S., Tretiakova M., Cohen G., Nguyen L., Hart J., Wang J., Wen M., Ramaswamy A., Joseph L., Sitrin M., Brasitus T., Bissonnette M., Ursodeoxycholic acid and F-D inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin Cancer Epidemiology Biomarkers and Prevention 2002 11 12 1653 1662 (Pubitemid 36020020)
85. Otori K., Sugiyama K., Fukushima S., Esumi H., Expression of the cyclin D1 gene in rat colorectal aberrant crypt foci and tumors induced by azoxymethane Cancer Letters 1999 140 1-2 99 104 (Pubitemid 29251319)
86. Kishimoto Y., Yashima K., Morisawa T., Shiota G., Kawasaki H., Hasegawa J., Effects of cyclooxygenase-2 inhibitor NS-398 on APC and c-myc expression in rat colon carcinogenesis induced by azoxymethane Journal of Gastroenterology 2002 37 3 186 193 (Pubitemid 34296216)
87. Takayama O., Yamamoto H., Damdinsuren B., Sugita Y., Ngan C. Y., Xu X., Tsujino T., Takemasa I., Ikeda M., Sekimoto M., Matsuura N., Monden M., Expression of PPAR in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology British Journal of Cancer 2006 95 7 889 895 (Pubitemid 44498105)
88. Roy H. K., Karolski W. J., Ratashak A., Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone International Journal of Cancer 2001 92 4 609 615 (Pubitemid 32327956)
89. Roy H. K., Olusola B. F., Clemens D. L., Karolski W. J., Ratashak A., Lynch H. T., Smyrk T. C., AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis Carcinogenesis 2002 23 1 201 205 (Pubitemid 34213570)
90. Thorup I., Histomorphological and immunohistochemical characterization of colonic aberrant crypt foci in rats: relationship to growth factor expression Carcinogenesis 1997 18 3 465 472 (Pubitemid 28132481)
91. Shao J., Sheng H., Aramandla R., Pereira M. A., Lubet R. A., Hawk E., Grogan L., Kirsch I. R., Washington M. K., Beauchamp R. D., DuBois R. N., Coordinate regulation of cyclooxygenase-2 and TGF- 1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors Carcinogenesis 1999 20 2 185 191 (Pubitemid 29057548)
92. Massagu J., TGF in Cancer Cell 2008 134 2 215 230
93. Spisni E., Strillacci A., Griffoni C., Valerii M. C., Lazzarini G., Tomasi V., RNAi-based strategies for cyclooxygenase-2 inhibition in cancer Journal of Biomedicine and Biotechnology 2010 2010
94. DuBois R. N., Radhika A., Reddy B. S., Entingh A. J., Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors Gastroenterology 1996 110 4 1259 1262 (Pubitemid 26113767)
95. Pere M., Zebic A., Cerar A., Rofecoxib does not inhibit aberrant crypt foci formation but inhibits later steps in the development of experimental colorectal cancer: rofecoxib in experimental colon cancer Scandinavian Journal of Gastroenterology 2005 40 1 61 67
96. Kawamori T., Takahashi M., Watanabe K., Ohta T., Nakatsugi S., Sugimura T., Wakabayashi K., Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor Cancer Letters 2000 148 1 33 37 (Pubitemid 30012126)
97. Kearney K. E., Pretlow T. G., Pretlow T. P., Increased expression of fatty acid synthase in human aberrant crypt foci: possible target for colorectal cancer prevention International Journal of Cancer 2009 125 1 249 252
98. Lau D. S. Y., Archer M. C., Fatty acid synthase is over-expressed in large aberrant crypt foci in rats treated with azoxymethane International Journal of Cancer 2009 124 11 2750 2753
99. Marzocchini R., Malentacchi F., Biagini M., Cirelli D., Luceri C., Caderni G., Raugei G., The expression of low molecular weight protein tyrosine phosphatase is up-regulated in 1,2-dimethylhydrazine-induced colon tumours in rats International Journal of Cancer 2008 122 7 1675 1678 (Pubitemid 351294979)
100. Devasena T., Menon V. P., Rajasekharan K. N., Prevention of 1,2-dimethylhydrazine-induced circulatory oxidative stress by bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione during colon carcinogenesis Pharmacological Reports 2006 58 2 229 235
101. Pere M., Injac R., trukelj B., Cerar A., Effects of high-fat mixed-lipid diet and exercise on the antioxidant system in skeletal and cardiac muscles of rats with colon carcinoma Pharmacological Reports 2009 61 5 909 916
102. Injac R., Perse M., Cerne M., Potocnik N., Radic N., Govedarica B., Djordjevic A., Cerar A., Strukelj B., Protective effects of fullerenol C(OH) against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer Biomaterials 2009 30 6 1184 1196
103. Sreedharan V., Venkatachalam K. K., Namasivayam N., Effect of morin on tissue lipid peroxidation and antioxidant status in 1, 2-dimethylhydrazine induced experimental colon carcinogenesis Investigational New Drugs 2009 27 1 21 30
104. Giftson J. S., Jayanthi S., Nalini N., Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1,2-dimethyl hydrazine induced rat colon carcinogenesis Investigational New Drugs 2010 28 3 251 259
105. Manju V., Balasubramaniyan V., Nalini N., Rat colonic lipid peroxidation and antioxidant status: the effects of dietary luteolin on 1,2-dimethylhydrazine challenge Cellular and Molecular Biology Letters 2005 10 3 535 551 (Pubitemid 41564523)
106. Samanta S., Swamy V., Suresh D., Rajkumar M., Rana B., Rana A., Chatterjee M., Protective effects of vanadium against DMH-induced genotoxicity and carcinogenesis in rat colon: removal of O-methylguanine DNA adducts, p53 expression, inducible nitric oxide synthase downregulation and apoptotic induction Mutation Research 2008 650 2 123 131
107. Sunter J. P., Appleton D. R., Wright N. A., Watson A. J., Pathological features of the colonic tumours induced in rats by the administration of 1,2-dimethylhydrazine Virchows Archiv B Cell Pathology 1978 29 1 211 223
108. McGarrity T. J., Peiffer L. P., Colony P. C., Cellular proliferation in proximal and distal rat colon during 1,2-dimethylhydrazine-induced carcinogenesis Gastroenterology 1988 95 2 343 348
109. Gamberini M., Cidade M. R., Valotta L. A., Armelin M. C. S., Leite L. C. C., Contribution of hydrazines-derived alkyl radicals to cytotoxicity and transformation induced in normal c-myc-overexpressing mouse fibroblasts Carcinogenesis 1998 19 1 147 155 (Pubitemid 28376837)
110. Hau J., Hau J., van Hoosier G., Animal models Handbook of Laboratory Animal Sience: Animal Models 2003 Boca Raton, Fla, USA CRC Press 1 9
111. Sohn O. S., Fiala E. S., Requeijo S. P., Weisburger J. H., Gonzalez F. J., Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol Cancer Research 2001 61 23 8435 8440 (Pubitemid 33131121)
112. Pere M., Cerar A., Dimethylhydrazine model is not appropriate for evaluating effect of ethanol on colorectal cancer Revista Espanola de Enfermedades Digestivas 2007 99 8 463 466
113. Noguera Aguilar J. F., Cuadrado Garca A., Ethanol and colic experimental carcinogenesisEtanol y carcinognesis clica experimental Revista Espanola de Enfermedades Digestivas 2007 99 8 438 43